SCHEMBL7978993

SCHEMBL7978993

C=C(c1ccc2ccccc2n1)c1ccccc1/C=C/[C]=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 1/20 0.42
▸ MGAM O43451 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPT P10636 5/20 0.41
▸ GAA P10253 2/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ NFKB1 P19838 2/20 0.40
▸ NFKB2 Q00653 2/20 0.40
▸ RELA Q04206 2/20 0.40
▸ CNR2 P34972 5/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658788 0.77 CES2 (0.39) HDAC8ALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL28443611 0.73 MGAM (0.61) HDAC8MGAMALDH1A1MAPTGAA
SCHEMBL8617775 0.72 MGAM (0.49) HDAC8MGAMALDH1A1MAPTGAA
SCHEMBL8414693 0.71 RAB9A (0.50) HDAC8MGAMALDH1A1MAPTGAA
SCHEMBL28605670 0.67 CNR2 (0.62) HDAC8MGAMALDH1A1MAPTGAA
SCHEMBL4261631 0.67 ALDH1A1 (0.48) HDAC8ALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL4261636 0.67 ALDH1A1 (0.48) HDAC8ALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL28139031 0.66 KDM4E (0.47) ALDH1A1MAPTGAARAB9AMEN1
SCHEMBL7978906 0.66 KDM4E (0.37) ALDH1A1MAPTSMN1; SMN2RAB9AMEN1
SCHEMBL5184717 0.66 MGAM (0.56) HDAC8MGAMALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 — — US disclosed
US-6127389-A TREATMENT OF HYPERTENSION, RENAL DISEASES, HEART FAILURE, HYPERTENSION, MENIERE'S DISEASE, PERIPHERAL AND CEREBRAL CIRCULATORY DISORDERS, CLIMACTERIC DISTURBANCE, RETINOCHOROIDAL CIRCULATORY DISORDERS, MYOCARDIAL ISCHEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-10-03 — — US disclosed
US-6083959-A BRADYKININ ANTAGONISTS; FOR THE PREVENTION AND/OR THE TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 — — US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 — — US disclosed
US-6015818-A TREATING KIDNEY, BRAIN, AND CARDIOVASCULAR DISORDERS; HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-01-18 — — US disclosed
EP-0900203-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-03-10 — — EP disclosed
EP-0879233-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-25 — — EP disclosed
WO-1997041104-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-06 — — WO disclosed
WO-1997028153-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-07 — — WO disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 — — EP disclosed
Send feedback